Influence of dibutyryl cyclic AMP on thymidine uptake by herpes simplex virus infected cells and the intracellular level of cyclic AMP.
Dibutyryl cyclic AMP inhibits the increase of dThd and BrdUrd transport normally observed after infection with Herpesvirus hominis, type I and II. Incorporation is also reduced. Inhibition of uptake is non-competitive as analysed by the Lineweaver-Burk plot. Addition of this drug to infected cells also reduces the activity of the thymidine kinase (EC 2.7.1.75). Transport of dUrd, dCyd and dAdo is not reduced. 4--8 h after infection with thymidine kinase (+) herpes strains the level of cAMP increases. On infection with a thymidine kinase (-) virus, only a small elevation  of cAMP can be shown. It was also found that early addition of actinomycin D or of cycloheximide prevents the increase of the cAMP level. This increase seems to depend on the activity of the herpes genome, because ultraviolet irradiation of infective particles destroys this ability.
D001692:Biological Transport; D001973:Bromodeoxyuridine / Q000378:metabolism; D003994:Bucladesine / Q000494:pharmacology*; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003853:Deoxyribonucleosides / Q000378:metabolism; D007700:Kinetics; D018139:Simplexvirus / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D013045:Species Specificity; D013936:Thymidine / Q000378:metabolism*; D013937:Thymidine Kinase / Q000378:metabolism; D013942:Thymine Nucleotides / Q000378:metabolism; D014466:Ultraviolet Rays; D014779:Virus Replication / Q000187:drug effects
D004279:DNA, Viral; D003853:Deoxyribonucleosides; D013942:Thymine Nucleotides; D003609:Dactinomycin; D003994:Bucladesine; D003513:Cycloheximide; D000242:Cyclic AMP; D013937:Thymidine Kinase; D001973:Bromodeoxyuridine; D013936:Thymidine